Antioxidant defence capacity modulation of two human cell lines by amiodarone and desethylamiodarone

Toxicology in Vitro : an International Journal Published in Association with BIBRA
J M TrivierM Lhermitte

Abstract

Although the role of oxidative stress has recently been the subject of increased discussion in relation to the pathogenesis of amiodarone (AMIO) toxicity, the cellular mechanisms underlying the hepatic and pulmonary disorders remain unknown. In order to investigate the effects of AMIO and its active metabolite desethylamiodarone (DEA) on the cellular antioxidant status, defence capacities of liver and lung cell lines have been first compared with published data on normal corresponding cells. Glutathione content, superoxide dismutase (SOD) and glutathione-related enzymes were then determined in Hep 3B and L132 cells, after AMIO and DEA treatment. Although no glutathione peroxidase could be detected in either cell line, Hep 3B and L132 cells were able to express normal glutathione S-transferase (GSH-S-T) and glutathione reductase (GSSG-Rd) activities. The principal targets of AMIO and DEA were, respectively, GSH-S-T and GSSG-Rd in Hep 3B cells, while SOD was significantly decreased by both drugs in L132 cells. Concomitantly, glutathione status (defined as the ratio of oxidized to total glutathione) was altered in Hep 3B but not in L132 cells. These findings suggest that the first step of amiodarone-induced Hep 3B and L132 cell le...Continue Reading

References

Jan 1, 1992·Life Sciences·S Uhlig, A Wendel
Apr 1, 1991·Toxicology Letters·R J RuchJ E Klaunig
Jan 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P SomaniS A Gross
Jul 1, 1988·Journal of Cardiovascular Pharmacology·T P KennedyG H Gurtner
Feb 1, 1989·Proceedings of the Society for Experimental Biology and Medicine·S A GrossP Somani
Jan 1, 1985·Methods in Enzymology·I Carlberg, B Mannervik
Feb 1, 1985·Medical Hypotheses·K L Nuttall
Mar 1, 1983·Journal of Analytical Toxicology·R H JaskotJ H Roycroft
May 1, 1995·Annals of Internal Medicine·P J Podrid
Jun 1, 1994·Canadian Journal of Physiology and Pharmacology·R G LeederT E Massey
Jun 1, 1994·Bulletin of Environmental Contamination and Toxicology·V HernoF Erb
Mar 1, 1994·Archives of Biochemistry and Biophysics·N AvissarH J Cohen
Apr 1, 1993·Journal of Cardiovascular Electrophysiology·A VereckeiJ Feher
Jul 1, 1993·Archives of Biochemistry and Biophysics·R D BakerP E Newburger
Nov 1, 1995·Clinical and Experimental Pharmacology & Physiology·C C Winterbourn
Sep 1, 1996·Proceedings of the Society for Experimental Biology and Medicine·M J Reasor, S Kacew
Dec 1, 1995·Canadian Journal of Physiology and Pharmacology·T E MasseyJ F Brien
Jan 1, 1996·Free Radical Biology & Medicine·V L KinnulaK Linnainmaa
Nov 1, 1992·Toxicology in Vitro : an International Journal Published in Association with BIBRA·V HernoF Erb

❮ Previous
Next ❯

Citations

Feb 24, 2007·Toxicology and Applied Pharmacology·Adrian C NicolescuThomas E Massey
Aug 11, 2000·Journal of Gastroenterology and Hepatology·H Jaeschke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.